Chemoinformaics analysis of 2-Pentenal, 4-methyl-
| Molecular Weight | 98.145 | nRot | 2 |
| Heavy Atom Molecular Weight | 88.065 | nRig | 2 |
| Exact Molecular Weight | 98.0732 | nRing | 0 |
| Solubility: LogS | -1.363 | nHRing | 0 |
| Solubility: LogP | 1.56 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 17.4899 |
| nHD | 0 | BPOL | 10.9001 |
| QED | 0.377 |
| Synth | 3.132 |
| Natural Product Likeliness | 2.291 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.007 |
| HIA | 0.005 |
| CACO-2 | -4.23 |
| MDCK | 0.0000305 |
| BBB | 0.998 |
| PPB | 0.520271 |
| VDSS | 1.353 |
| FU | 0.452339 |
| CYP1A2-inh | 0.379 |
| CYP1A2-sub | 0.225 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.873 |
| CYP2c9-inh | 0.021 |
| CYP2c9-sub | 0.533 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.599 |
| CYP3a4-inh | 0.02 |
| CYP3a4-sub | 0.294 |
| CL | 6.695 |
| T12 | 0.712 |
| hERG | 0.014 |
| Ames | 0.841 |
| ROA | 0.92 |
| SkinSen | 0.93 |
| Carcinogencity | 0.884 |
| EI | 0.994 |
| Respiratory | 0.964 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.952376 |